Search

everythinglearnresearchcommunity

for

Search:↓

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Increased awareness and research are needed to prevent hair loss from cosmetic procedures.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Long-term diabetes, smoking, and poor blood sugar control increase the risk of artery disease in diabetic retinopathy patients.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Hyperandrogenism in women can cause acne, hair growth, hair loss, irregular periods, and increase the risk of infertility and diabetes.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Finasteride treats baldness but may cause lasting sexual side effects.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.